Pharmaceutical Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET OVERVIEW
Pharmaceutical is a broad segment that consolidates a group of chemicals classified based on their pharmacological effect and therapeutic use. For instance, Alkaloids were the first pure pharmaceuticals derived from plants; they include quinine, nicotine, cocaine, atropine, and morphine. Similarly, some drugs are made of animal origin, which includes glandular extracts containing hormones. Drugs or medicines from animal origins are biological, biosimilar, and vaccines. These pharmaceutical products diagnose, treat, and prevent chronic diseases like cancer, diabetes, and genetic disorders.
MARKET SCOPE
The "Global Pharmaceutical Analysis to 2028" is a specialized and in-depth examination of the healthcare industry, with a particular emphasis on global market trend analysis. The purpose of this report is to provide an overview of the pharmaceutical market, as well as detailed market segmentation based on product. Additionally, the report offers key statistics on the market status of the leading pharmaceutical market players, as well as key market trends and opportunities.
MARKET SEGMENTATION
- Based on product, the market is segregated into branded drugs, generics, biological and biosimilar products, vaccines, and others.
MARKET DYNAMICS
Drivers-
- Growing prevalence of chronic and acute diseases
- Rising research and developments in the pharmaceutical industry
- Increasing production of pharmaceutical products
Restraint-
- Stringent regulations from regulatory bodies and increasing product recall
The report offers a comprehensive overview of the industry, including both qualitative and quantitative data. It provides a global market overview and forecast based on various segments. It also provides market size and forecast estimates of country-wise statistics from 2022 to 2028. Each region's pharmaceutical market is further subdivided by respective countries and segments.
The report analyses market factors affecting both the demand and supply sides, as well as market dynamics affecting the market during the forecast period, such as drivers, restraints, opportunities, and future trends. The report also includes a comprehensive PEST analysis for Brazil after assessing the political, economic, social, and technological factors influencing the pharmaceutical market in these regions.
Impact of COVID-19 on Pharmaceutical Market
The ongoing COVID-19 pandemic has imposed a heavy toll on human life, health care, the global economy, and almost every aspect of human life. The COVID-19 pandemic has impacted all drug development phases and forced many drug development companies and clinical research organizations to put at least some of their clinical studies on hold. Despite these devastating effects, COVID-19 has also mobilized and united many drug discovery and development elements in seeking therapies to address this most pressing public health emergency. The COVID-19 pandemic also has impacted the supply of active materials and ingredients and the import and export of pharmaceuticals.
Mrinal Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any. Have a question?
The report offers a comprehensive overview of the industry, including both qualitative and quantitative data. It provides a global market overview and forecast based on various segments. It also provides market size and forecast estimates of country-wise statistics from 2022 to 2028. Each region's pharmaceutical market is further subdivided by respective countries and segments.
The report analyses market factors affecting both the demand and supply sides, as well as market dynamics affecting the market during the forecast period, such as drivers, restraints, opportunities, and future trends. The report also includes a comprehensive PEST analysis for Brazil after assessing the political, economic, social, and technological factors influencing the pharmaceutical market in these regions.
Impact of COVID-19 on Pharmaceutical Market
The ongoing COVID-19 pandemic has imposed a heavy toll on human life, health care, the global economy, and almost every aspect of human life. The COVID-19 pandemic has impacted all drug development phases and forced many drug development companies and clinical research organizations to put at least some of their clinical studies on hold. Despite these devastating effects, COVID-19 has also mobilized and united many drug discovery and development elements in seeking therapies to address this most pressing public health emergency. The COVID-19 pandemic also has impacted the supply of active materials and ingredients and the import and export of pharmaceuticals.
MARKET PLAYERS
The report covers key developments in the pharmaceutical market with a focus on two main strategies such as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies that include new product launches, product approvals by authorized bodies, and others such as patents and events. Inorganic growth strategies activities normally include strategic acquisitions and, partnerships & collaborations between the companies. These activities have paved the way for the expansion of business and the customer base of market players. The market payers from the pharmaceutical market are anticipated to have lucrative growth opportunities with the rising demand for pharmaceuticals in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the pharmaceutical market. Also, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, and the key development in the past five years.
- Johnson & Johnson
- Pfizer Inc.
- Merck & Co., Inc.
- Abbott Laboratories
- Amgen Inc.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Celgene Corporation
- Shire plc
- Zoetis Inc.
The Insight Partner’s dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pharmaceutical Market - By Product
1.3.2 Pharmaceutical Market - By Region
1.3.2.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PHARMACEUTICAL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PHARMACEUTICAL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PHARMACEUTICAL MARKET - GLOBAL MARKET ANALYSIS
6.1. PHARMACEUTICAL - GLOBAL MARKET OVERVIEW
6.2. PHARMACEUTICAL - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. PHARMACEUTICAL MARKET - REVENUE AND FORECASTS TO 2028 – PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. BRANDED DRUGS
7.3.1. Overview
7.3.2. Branded Drugs Market Forecast and Analysis
7.4. GENERICS
7.4.1. Overview
7.4.2. Generics Market Forecast and Analysis
7.5. BIOLOGICAL AND BIOSIMILAR PRODUCTS
7.5.1. Overview
7.5.2. Biological and Biosimilar Products Market Forecast and Analysis
7.6. VACCINES
7.6.1. Overview
7.6.2. Vaccines Market Forecast and Analysis
7.7. OTHERS
7.7.1. Overview
7.7.2. Others Market Forecast and Analysis
8. PHARMACEUTICAL MARKET REVENUE AND FORECASTS TO 2028 – GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1 North America Pharmaceutical Market Overview
8.1.2 North America Pharmaceutical Market Forecasts and Analysis
8.1.3 North America Pharmaceutical Market Forecasts and Analysis - By Product
8.1.4 North America Pharmaceutical Market Forecasts and Analysis - By Countries
8.1.4.1 United States Pharmaceutical Market
8.1.4.1.1 United States Pharmaceutical Market by Product
8.1.4.2 Canada Pharmaceutical Market
8.1.4.2.1 Canada Pharmaceutical Market by Product
8.1.4.3 Mexico Pharmaceutical Market
8.1.4.3.1 Mexico Pharmaceutical Market by Product
8.2. EUROPE
8.2.1 Europe Pharmaceutical Market Overview
8.2.2 Europe Pharmaceutical Market Forecasts and Analysis
8.2.3 Europe Pharmaceutical Market Forecasts and Analysis - By Product
8.2.4 Europe Pharmaceutical Market Forecasts and Analysis - By Countries
8.2.4.1 Germany Pharmaceutical Market
8.2.4.1.1 Germany Pharmaceutical Market by Product
8.2.4.2 France Pharmaceutical Market
8.2.4.2.1 France Pharmaceutical Market by Product
8.2.4.3 Italy Pharmaceutical Market
8.2.4.3.1 Italy Pharmaceutical Market by Product
8.2.4.4 Spain Pharmaceutical Market
8.2.4.4.1 Spain Pharmaceutical Market by Product
8.2.4.5 United Kingdom Pharmaceutical Market
8.2.4.5.1 United Kingdom Pharmaceutical Market by Product
8.2.4.6 Rest of Europe Pharmaceutical Market
8.2.4.6.1 Rest of Europe Pharmaceutical Market by Product
8.3. ASIA-PACIFIC
8.3.1 Asia-Pacific Pharmaceutical Market Overview
8.3.2 Asia-Pacific Pharmaceutical Market Forecasts and Analysis
8.3.3 Asia-Pacific Pharmaceutical Market Forecasts and Analysis - By Product
8.3.4 Asia-Pacific Pharmaceutical Market Forecasts and Analysis - By Countries
8.3.4.1 Australia Pharmaceutical Market
8.3.4.1.1 Australia Pharmaceutical Market by Product
8.3.4.2 China Pharmaceutical Market
8.3.4.2.1 China Pharmaceutical Market by Product
8.3.4.3 India Pharmaceutical Market
8.3.4.3.1 India Pharmaceutical Market by Product
8.3.4.4 Japan Pharmaceutical Market
8.3.4.4.1 Japan Pharmaceutical Market by Product
8.3.4.5 South Korea Pharmaceutical Market
8.3.4.5.1 South Korea Pharmaceutical Market by Product
8.3.4.6 Rest of Asia-Pacific Pharmaceutical Market
8.3.4.6.1 Rest of Asia-Pacific Pharmaceutical Market by Product
8.4. MIDDLE EAST AND AFRICA
8.4.1 Middle East and Africa Pharmaceutical Market Overview
8.4.2 Middle East and Africa Pharmaceutical Market Forecasts and Analysis
8.4.3 Middle East and Africa Pharmaceutical Market Forecasts and Analysis - By Product
8.4.4 Middle East and Africa Pharmaceutical Market Forecasts and Analysis - By Countries
8.4.4.1 South Africa Pharmaceutical Market
8.4.4.1.1 South Africa Pharmaceutical Market by Product
8.4.4.2 Saudi Arabia Pharmaceutical Market
8.4.4.2.1 Saudi Arabia Pharmaceutical Market by Product
8.4.4.3 U.A.E Pharmaceutical Market
8.4.4.3.1 U.A.E Pharmaceutical Market by Product
8.4.4.4 Rest of Middle East and Africa Pharmaceutical Market
8.4.4.4.1 Rest of Middle East and Africa Pharmaceutical Market by Product
8.5. SOUTH AND CENTRAL AMERICA
8.5.1 South and Central America Pharmaceutical Market Overview
8.5.2 South and Central America Pharmaceutical Market Forecasts and Analysis
8.5.3 South and Central America Pharmaceutical Market Forecasts and Analysis - By Product
8.5.4 South and Central America Pharmaceutical Market Forecasts and Analysis - By Countries
8.5.4.1 Brazil Pharmaceutical Market
8.5.4.1.1 Brazil Pharmaceutical Market by Product
8.5.4.2 Argentina Pharmaceutical Market
8.5.4.2.1 Argentina Pharmaceutical Market by Product
8.5.4.3 Rest of South and Central America Pharmaceutical Market
8.5.4.3.1 Rest of South and Central America Pharmaceutical Market by Product
9. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PHARMACEUTICAL MARKET
9.1 North America
9.2 Europe
9.3 Asia-Pacific
9.4 Middle East and Africa
9.5 South and Central America
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. PHARMACEUTICAL MARKET, KEY COMPANY PROFILES
11.1. JOHNSON AND JOHNSON
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. PFIZER INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. MERCK AND CO., INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. ABBOTT LABORATORIES
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. AMGEN INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ELI LILLY AND COMPANY
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BRISTOL-MYERS SQUIBB COMPANY
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. CELGENE CORPORATION
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. SHIRE PLC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ZOETIS INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
- Johnson & Johnson
- Pfizer Inc.
- Merck & Co., Inc.
- Abbott Laboratories
- Amgen Inc.
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Celgene Corporation
- Shire plc
- Zoetis Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.